Benitec Biopharma Statistics
NASDAQ: BNTCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.92-0.225 (-2.76%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Benitec Biopharma by the numbers
Benitec Biopharma has a market capitalization of $285.9 million based on 36.12M shares outstanding. With trailing EPS of $-1.02, Benitec Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.4% below its 50-day average and 29.9% below its 200-day average.
Average daily trading volume is 174.01K shares, or about $1.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BNTC valuation vs. peer median
| Metric | BNTC | Peer median | Difference |
|---|---|---|---|
| Market cap | $285.88M | $280.69M | +2% |
| Avg. volume | 174.01K | 976.07K | -82% |
Peer median across 8 companies: GLSI, FULC, EVMN, RLMD, SPRY, GALT, VCRE, EBS.
Valuation
- Market cap
- $285.88M
- EPS (TTM)
- $-1.02
- Shares outstanding
- 36.12M
Price and trading
- Previous close
- 8.14
- Open
- 8.00
- Day range
- 7.75 – 8.16
- 52-week range
- 7.72 – 14.39
- 52-week change
- -40.31%
- Beta
- —
- Volume
- 268.68K
- Average volume
- 174.01K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 13, 2026
Additional statistics
- Market Cap
- 285.88M
- Forward Pe
- -0.84
- Eps
- -1.02
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.39
- Week52 Low
- 7.72
- Avg Volume
- 174.01K
- Shares Outstanding
- 36.12M
- Ma50
- 9.25
- Ma200
- 11.28
- Earnings Date
- Nov 13, 2026
- Pct From52w High
- -45.00%
- Pct From52w Low
- 2.53%